Healthcare
Technology
People

Healthcare
Technology
People

Portfolio
People
News
Stories
About
Fintech Index
FBRI
Jobs

Search for:

Find a portfolio company, person, community initiative, or story

News

Category

Enterprise IT
FinTech
FrontierTech
Health IT/Services
MedTech
Other
Therapeutics

GlobeNewswire

Orchard Therapeutics Receives EC Approval for Libmeldy™ for the Treatment of Early-Onset Metachromatic Leukodystrophy (MLD)
December 21, 2020
PR Newswire

FARAPULSE’s Pivotal Trial to Assess Its Leading Pulsed Field Ablation System for The Treatment of Atrial Fibrillation Receives FDA Conditional Approval
December 17, 2020
Business Wire

Kyruus and HealthSparq Come Together to Transform Care Navigation Through Novel Payer-Provider Collaboration
December 17, 2020
Endpoints News

GlaxoSmithKline plumbs the discovery field (again), betting up to $815M for the latest add-on to its oncology pipeline
December 17, 2020
PR Newswire

Blueprint Medicines Submits Supplemental New Drug Application to FDA for AYVAKIT™ (avapritinib) for the Treatment of Advanced Systemic Mastocytosis
December 17, 2020
Business Wire

NodThera Appoints Chief Medical Officer and Chief Financial Officer
December 15, 2020
Crunchbase

Mozper Banks $3.55M To Develop Debit Card, App For LatAm Children
December 14, 2020
PR Newswire

Innovent Announces First Patient Dosed in Phase 2 Pivotal Trial of IBI310 (CTLA-4) combined with TYVYT® (sintilimab injection) for the treatment of second-line or above Advanced Cervical Cancer
December 10, 2020
GlobeNewswire

Ultragenyx Announces Orphan Drug Designation for UX701 for the Treatment of Wilson Disease
December 9, 2020
PR Newswire

Vestwell Partners with Envestnet to Offer Turnkey Retirement Plan Solutions to Industry Advisors
December 9, 2020
GlobeNewswire

Orchard Therapeutics Reports OTL-201 Initial Clinical Data in Sanfilippo Syndrome Type A (MPS-IIIA)
December 8, 2020
GlobeNewswire

Flywire Reports Record Growth for Digital Healthcare Payments Platform
December 8, 2020
GlobeNewswire

Checkmate Pharmaceuticals Announces Clinical Collaboration with Bristol Myers Squibb to Evaluate CMP-001 in Combination with Nivolumab
December 8, 2020
Crunchbase

Centivo Secures $34M Series B To Scale Self-funded Employer Health Plan
December 7, 2020
PR Newswire

Innovent Announces Parsaclisib Treatment Results in High Rate of Rapid and Durable Responses in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas
December 7, 2020
GlobeNewswire

Precision BioSciences Reports Positive Interim Results from PBCAR0191 Phase 1/2a Trial in Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL) and R/R B-cell Acute Lymphoblastic Leukemia (B-ALL)
December 4, 2020
GlobeNewswire

Adagene Announces Expansion of Leadership Team to Support Strategic Growth
December 2, 2020
Business Wire

ConnexPay Raises Additional Funding to Propel Adoption of Payments Technology
December 1, 2020
Business Wire

Turnstone Biologics Announces First Patients Enrolled in Phase 1/2 Clinical Trial Evaluating RIVAL-01 For the Treatment of Solid Tumors
December 1, 2020
PR Newswire

OTA Insight Announces Atomize is First RMS to Ingest Company’s Revolutionary New Forward-Looking Data Sets
December 1, 2020
PR Newswire

Blueprint Medicines Announces FDA Approval of GAVRETO™ (pralsetinib) for the Treatment of Patients with Advanced or Metastatic RET-Mutant and RET Fusion-Positive Thyroid Cancer
December 1, 2020
PR Newswire

Innovent Releases Phase 3 Results of TYVYT® (Sintilimab Injection) in Combination with BYVASDA® (Bevacizumab Biosimilar Injection) as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma (HCC) at ESMO ASIA Virtual Congress 2020
November 22, 2020
FierceBiotech

Lilly, Precision Biosciences team up on Duchenne gene therapy in $135M deal
November 20, 2020
GlobeNewswire

Orchard Therapeutics Announces FDA Clearance of IND Application for OTL-200 for Metachromatic Leukodystrophy (MLD)
November 19, 2020
PR Newswire

Toast Leadership Team Named Entrepreneur Of The Year® 2020 National Overall Award Winner
November 19, 2020
Business Wire

Caribou Biosciences Announces Licensing Agreement for scFvs Targeting CD371 to Enable Development of Allogeneic Cell Therapies
November 18, 2020
GlobeNewswire

Apellis Announces FDA Acceptance and Priority Review of the New Drug Application for Pegcetacoplan for the Treatment of PNH
November 16, 2020
PR Newswire

Innovent Announces the Results of the Phase I Clinical Trial of IBI302, a First-in-class Ophthalmic Recombinant Human Anti-VEGF and Anti-Complement Bi-specific Fusion Protein for Neovascular Age-Related Macular Degeneration at 2020 American Academy of Ophthalmology
November 15, 2020
GlobeNewswire

Surface Oncology Announces SRF617 and SRF388 Will Advance to Combination and Expansion Stages of Ongoing Phase 1 Clinical Trials
November 13, 2020
GlobeNewswire

Beam Therapeutics Presents First Data Highlighting Base Editing Program for Glycogen Storage Disease Type Ia at AASLD
November 13, 2020
Business Wire

Xilio Therapeutics Presents Promising Preclinical Tumor-Selective Efficacy and Safety Data for XTX201 (IL-2) and XTX101 (anti-CTLA-4) at SITC
November 12, 2020
PR Newswire

Whatfix To Host Second Virtual Digital Adoption Conference
November 10, 2020
Business Wire

Rallybio Announces First-in-Human Dosing in RLYB211 Phase 1/2 Study
November 10, 2020
PR Newswire

PatientPing Partners with MedAllies to Ensure Hospital Partners’ Compliance with CMS E-Notifications Condition of Participation
November 10, 2020
GlobeNewswire

Denali Therapeutics Announces First Human Biomarker Proof of Concept for Its Transport Vehicle (TV) Technology Achieved in Phase 1/2 Study of ETV:IDS (DNL310) in Hunter Syndrome (MPS II)
November 10, 2020
PR Newswire

Innovent Releases Phase 1a Results of CD47 Monoclonal Antibody (Letaplimab) in Monotherapy for Advanced Malignancies at SITC 2020
November 10, 2020
GlobeNewswire

Two Confirmed Responses and Five out of Six Patients with Initial Tumor Reductions from Early Dose Cohorts of SURPASS Trial, Presented at SITC
November 9, 2020
PR Newswire

Insilico announces a multi-target AI-powered drug discovery collaboration with Janssen
November 9, 2020
GlobeNewswire

Beam Therapeutics Names First CAR-T Base Editing Development Candidate for the Treatment of T-ALL and Presents New Data at SITC 2020
November 9, 2020
GlobeNewswire

Orchard Therapeutics Announces New OTL-201 Clinical Data in Sanfilippo Syndrome Type A (MPS-IIIA) Accepted for Oral Presentation at 62nd American Society of Hematology Annual Meeting
November 5, 2020
GlobeNewswire

Innovent and Lilly Jointly Announce Results of Seven Clinical Studies of TYVYT® (sintilimab injection) to Be Presented at the ESMO ASIA Congress 2020
November 4, 2020
PR Newswire

Sana Biotechnology Announces Acquisition of Oscine
October 30, 2020
Endpoints News

Chinese rare disease player inks first deal around narcolepsy drug Wakix after grabbing $80M to build an ecosystem
October 28, 2020
Crunchbase

French Scale-up Odaseva Raises $25M To Continue Global Expansion
October 27, 2020
Business Wire

Baptist Health Engages Kyruus to Enable Next-Generation Online Patient Access Experience
October 27, 2020
PR Newswire

Apricus Health Partners with Medicare Advantage Plan Devoted Health and Full-Service Retail Pharmacy Liton Rx
October 27, 2020
PR Newswire

Arcadia Expands Partnership with PatientPing, Enhancing Access to Real-Time Patient Data for Healthcare Organizations
October 27, 2020
The Irish Sun

Irish device that kills 99.999 per cent of Covid in air ‘could help end lockdown’ and get businesses open
October 26, 2020
GlobeNewswire

Ultragenyx and Solid Biosciences Announce Strategic Collaboration to Develop and Commercialize New Gene Therapies for Duchenne Muscular Dystrophy
October 23, 2020
GlobeNewswire

Orchard Therapeutics CEO Bobby Gaspar, M.D., Ph.D., Appointed to the Alliance for Regenerative Medicine’s 2021 Board of Directors
October 22, 2020
FierceBiotech

Compass aims at $50M IPO to push lead antibody through the clinic
October 20, 2020
PR Newswire

TraceLink Announces New Serialized Product Intelligence Solution
October 20, 2020
PR Newswire

PatientPing Commends Its Community of MSSP Accountable Care Organizations for Generating Over $517 Million in Shared Savings – a 20% Improvement Over Last Year
October 20, 2020
PR Web

Devoted Health Launches Compassionate, Affordable Medicare Advantage Plans in Arizona
October 20, 2020
Business Wire

Wellframe Partners with ZeOmega to Help Health Plans Offer an Enhanced Digital Experience
October 19, 2020
GlobeNewswire

Orchard Therapeutics Receives Positive CHMP Opinion for Libmeldy™ for the Treatment of Early-Onset Metachromatic Leukodystrophy (MLD)
October 16, 2020
GlobeNewswire

Adaptimmune Provides Full Contents of its SITC Abstract for the Phase 1 SURPASS Trial
October 15, 2020
PR Newswire

Insilico partners with Taisho on end-to-end AI-powered senolytic drug discovery
October 15, 2020
ACN News

Hua Medicine Announces the Drug Manufacturing Permit Granted for Dorzagliatin
October 13, 2020
TechCrunch

Snapdocs raises $60M to manage the mortgage process in the cloud
October 12, 2020
PR Newswire

Innovent and Lilly Jointly Announce the NMPA Granted Marketing Approval for HALPRYZA® (Rituximab Injection) in China
October 9, 2020
GlobeNewswire

Denali Therapeutics Announces Closing of Collaboration and Share Purchase Agreements with Biogen
October 7, 2020
GlobeNewswire

Flywire Announces Partnership with Brazilian Educational & Language Travel Association (BELTA)
October 7, 2020
Business Wire

Caribou Biosciences Co-Founder Dr. Jennifer Doudna Awarded Nobel Prize in Chemistry
October 7, 2020
GlobeNewswire

Acacia Pharma announces BYFAVO™ (remimazolam), its Newly Approved Product for Procedural Sedation, Clears Final Hurdle on Path to Commercial Launch in the US
October 6, 2020
GlobeNewswire

ProcessUnity and RiskRecon Partner to Provide Customers Access to Data-Driven Third-Party Security Ratings
October 6, 2020
PR Newswire

Applied BioMath, LLC Announces Two-Year Strategic Partnership with Xilio Therapeutics
October 5, 2020
PR Newswire

Unum Therapeutics Announces Company Name Change to Cogent Biosciences, Highlights Recent Scientific and Operational Progress
October 5, 2020
PR Newswire

TraceLink VRS Solution Implemented by Henry Schein Months Ahead of Deadline for DSCSA Saleable Returns Verification Requirement
September 30, 2020
Business Wire

Xilio Therapeutics Appoints Rachel Humphrey, M.D. to Board of Directors
September 29, 2020
GlobeNewswire

Orchard Therapeutics Receives EMA PRIME Designation for OTL-203 for the Treatment of MPS-I
September 28, 2020
GlobeNewswire

Beam Therapeutics Announces Proposed Public Offering of Common Stock
September 28, 2020
PR Newswire

Blueprint Medicines Announces European Commission Approval of AYVAKYT® (avapritinib) for the Treatment of Adults with Unresectable or Metastatic PDGFRA D842V Mutant Gastrointestinal Stromal Tumors
September 25, 2020
BioPharma Journal

Precision BioSciences Inc. (NASDAQ:DTIL) Receives Fast Track Designation For PBCAR269A For Refractory/Relapsed Multiple Myeloma
September 25, 2020
PR Newswire

Benchling Appoints Biotech and SaaS Veterans to Board of Directors
September 23, 2020
GlobeNewswire

Flywire Announces Foundation Scholarship Winners for Fall 2020
September 23, 2020
PR Newswire

Whatfix for ISVs is Now Available, Helping Partners and Customers Accelerate Technology Adoption and Digital Transformation
September 22, 2020
PR Newswire

Blueprint Medicines Announces Positive Top-line Results from EXPLORER and PATHFINDER Trials of AYVAKIT™ (avapritinib) in Patients with Advanced Systemic Mastocytosis
September 22, 2020
GlobeNewswire

Getaround Selects Snapsheet’s End-to-End Digital Claims Management Platform
September 22, 2020
GlobeNewswire

Precision BioSciences and SpringWorks Therapeutics Announce Clinical Collaboration to Evaluate PBCAR269A in Combination with Nirogacestat in Patients with Relapsed or Refractory Multiple Myeloma
September 21, 2020
PR Newswire

Boston Scientific Announces Expanded Investment and Exclusive Acquisition Option Agreement with Farapulse, Inc.
September 21, 2020
PR Newswire

Innovent and Lilly Jointly Release Phase 3 Results of TYVYT® (Sintilimab Injection) in Combination with GEMZAR® (Gemcitabine) and Platinum Chemotherapy as First-Line Treatment for Squamous Non-Small Cell Lung Cancer at ESMO Virtual Congress 2020
September 21, 2020
PR Newswire

Blueprint Medicines Reports ARROW Trial Data at ESMO Virtual Congress 2020 Demonstrating Durable Clinical Benefits of GAVRETO™ (Pralsetinib) in Patients with Advanced RET-Mutant Medullary Thyroid Cancer
September 20, 2020
PR Newswire

Blueprint Medicines Presents Foundational Preclinical Data for BLU-945 Showing Robust Anti-Tumor Activity in Treatment-Resistant EGFR-Mutated Lung Cancer at ESMO Virtual Congress 2020
September 17, 2020
GlobeNewswire

Precision BioSciences and Servier Expand CAR T Oncology Development Collaboration with Four New Programs Targeting Hematological and Solid Tumors
September 17, 2020
GlobeNewswire

Flywire and Mastercard Team Up to Simplify Cross-Border Tuition Payments
September 17, 2020
GlobeNewswire

NTU Singapore and Flywire partner to offer new digital payment platform for international students
September 16, 2020
Business Wire

Wellframe’s Melissa Herman Named 2020 CFO of the Year by Boston Business Journal
September 15, 2020
PR Newswire

Carrot Fertility Partners with CCRM Fertility Expanding Member Access to High-Quality Fertility Care
September 15, 2020
PR Newswire

Innovent and Lilly Jointly Announce Results of Six Clinical Studies of TYVYT® (sintilimab injection) to be Presented at the European Society for Medical Oncology (ESMO) Virtual Congress 2020
September 14, 2020

page 1 1
page 2 2
page 3 3
page 4 4
page 5 5
page 6 6
page 7 7
page 8 8
page 9 9
page 10 10
page 11 11
page 12 12
page 13 13
page 14 14
page 15 15
page 16 16
page 17 17
page 18 18
page 19 19
page 20 20

We create and invest in healthcare and technology companies that improve lives all over the world.

Jump to —

Portfolio
People
News
Stories
About
Fintech Index
FBRI
Jobs

Cambridge
1 Main St.
13th Floor
Cambridge, MA 02142
London
33 Foley Street
London, W1W 7TL
San Francisco
140 New Montgomery Street
2nd Floor, Suite A
San Francisco, CA 94105

© 2022
Terms of Use
Privacy Policy
Stay in Touch

The information on these pages is intended solely for the benefit of entrepreneurs seeking venture capital investments. F-Prime is not offering investment advisory services nor is it offering to sell securities. F‑Prime provides advisory services as Impresa Management LLC. The list of portfolio companies includes investments made by Fidelity Ventures and Eight Roads. FBRI is an affiliate of F‑Prime and a subsidiary of FMR LLC.